Ticker Launch

London · AIM · IPO · BVX

BiVictriX plc (to become BiVictriX Therapeutics plc)

BiVictriX plc (to become BiVictriX Therapeutics plc) (BVX) was admitted to AIM, raising £7.5M at 20p per share. Its market capitalization at admission was about £13.2M.

BiVictriX plc, to be renamed BiVictriX Therapeutics plc, is seeking admission to AIM with a £7.5 million placing.

Type
IPO
Market
AIM
Ticker (TIDM)
BVX
Offer price
20p
Raised
£7.5M
Market cap at admission
£13.2M
Sector
Biotech & pharma
Country
United Kingdom

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Sources

From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.